SELLAS Life Sciences (SLS) Return on Capital Employed Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 68,255.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 2,665.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 31,429.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 2,503.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -105.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 2,400.00
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - 10,252.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10,252.00
Dec 31, 2025 18,534.00
Sep 30, 2025 24,651.00
Jun 30, 2025 35,178.00
Mar 31, 2025 393,586.00
Dec 31, 2024 -80,945.00
Sep 30, 2024 213,864.00
Jun 30, 2024 -9,561.00
Mar 31, 2024 -368,975.00
Dec 31, 2023 110,251.00
Sep 30, 2023 -219,340.00
Jun 30, 2023 -5,424.00
Mar 31, 2023 -8,171.00
Dec 31, 2022 -43,398.00
Sep 30, 2022 -21,628.00
Jun 30, 2022 -25,977.00
Mar 31, 2022 -26,135.00
Dec 31, 2021 -807.00
Sep 30, 2021 12,382.00
Jun 30, 2021 14,619.00
Mar 31, 2021 12,639.00
Dec 31, 2017 -8,839.00
Sep 30, 2017 8,389.00
Jun 30, 2017 12,593.00
Mar 31, 2017 -46,766.00
Dec 31, 2016 8,787.00
Sep 30, 2016 -3,926.00
Jun 30, 2016 -9,398.00
Mar 31, 2016 -3,280.00
Dec 31, 2015 -4,428.00
Sep 30, 2015 2,781.00
Jun 30, 2015 2,159.00
Mar 31, 2015 -2,092.00
Dec 31, 2014 1,418.00
Sep 30, 2014 -2,610.00
Jun 30, 2014 -709.00
Mar 31, 2014 164.00
Dec 31, 2013 1,303.00